AI-Moderated Healthcare Research

AI-moderated clinician research, built for healthcare

Verified clinician panel. HIPAA-compliant by default. Specialty studies delivered in 3 weeks with the compliance posture pharma and hospital procurement actually requires.

BAA on every healthcare engagement
Monthly subscription with 50 interviews included
0.4% verified AI-respondent leak rate
Verified clinician on a Carevoices research interview
Live
carevoices.health/dashboard
Study Dashboard 3 Active
0
Verified clinicians
▲ 2.1%
0
Brief to delivery
▲ 3.5%
0
AI-respondent leak
▼ 1.2%
Response Trend 7 days
Choose study type
Buying Process
Message Validation
Concept Testing
Advisory
Tracker
Workforce
0.4% AI-respondent leak ▲ 2.1%
78% Complete
Live

Trusted by teams at

Nivella Health
What It Is

What Is Carevoices?

Carevoices is an AI-moderated qualitative research platform purpose-built for healthcare. We recruit verified clinicians, run voice and video interviews with them, and deliver HIPAA-grade de-identified transcripts to your team — in 3 weeks, with the compliance posture pharma and hospital procurement actually requires.

The platform's AI moderator runs structured voice and video interviews with verified nurses, NPs, physicians, and specialists from our panel of 10k+ healthcare practitioners. License + NPI verification at intake. Behavioral fingerprinting builds across interviews to detect AI-assisted respondents — a capability legacy survey panels structurally cannot match.

Compliance posture is the wedge, not an afterthought. Every healthcare engagement includes a Business Associate Agreement. Transcripts are de-identified using HIPAA Safe Harbor methodology before delivery. PHI never trains a model. All data stays in US AWS and GCP regions, confirmed in writing in your contract.

Carevoices is a monthly subscription with 50 interviews included — always-on listening capability that replaces bespoke per-project RFP cycles. Buying-process studies, nurse qualitative research, message validation, concept testing, advisory, tracker waves, and KOL deep-dives all run within the same subscription. Additional interviews above 50/month are available at the standard credit rate. Customers use their own analysis stack — internal data scientists, MarketSight, Forsta, Claude Enterprise — on the transcripts we deliver. We feed the data your existing vendors can't recruit for.

The Problem

Why Generic AI Research Tools Fail Healthcare

Most AI research tools were built for consumer brands. They can't sign a BAA. They don't have a verified clinician panel. They weren't designed to handle PHI safely. Healthcare buyers have been forced to choose between AI-native speed and regulatory rigor.

1

No BAA = Disqualified

Pharma compliance, hospital procurement, and medtech legal all require Business Associate Agreements before any vendor touches PHI. Generic AI research tools either can't sign one or take 90 days to add the capability — both kill the engagement.

2

Specialty Recruiting Takes Weeks

Finding 25 GI oncology specialists, 50 OR nurses, or 30 cardiologists is the bottleneck on every custom study. Most vendors quote 6-10 weeks for fielding alone before analysis even begins. Trackers help; ad-hoc research is brutal.

3

Compliance Treated as Bolt-On, Not Architecture

AI research tools claim BAA capability without infrastructure to back it up. When your compliance team digs in, the vendor either backs off or asks for a 90-day delay. Both kill the engagement before fielding starts.

4

Identifier Stripping Is Manual or Missing

Most legacy vendors treat de-identification as a post-fielding service charge. Generic AI tools skip it entirely. Healthcare buyers need HIPAA Safe Harbor de-identification built into the delivery pipeline by default.

Results

What Teams Value Most

What matters most to teams after switching to AI-moderated research.

Fielding starts the week the brief is locked
Same week

Verified panel of 10k+ nurses, NPs, physicians, and specialists. License + NPI verified. Pre-profiled by specialty and behavioral fingerprint. Monthly subscription with 50 interviews included means always-on listening capability vs. per-project RFP cycles at incumbent vendors.

Healthcare engagements covered by BAA
100%

HIPAA-compliant pipeline. BAA on every engagement (template available pre-signature). HIPAA Safe Harbor de-identification by default. US data residency, AWS / GCP US regions only. PHI never trains a model — period.

Verified AI-respondent leak rate
0.4%

PNAS 2025 research shows AI bots evade legacy fraud detection 99.8% of the time. Carevoices' 6-Layer Fraud Detection Stack — including the AI-on-AI Detection Layer — measured 0.4% leak rate in Q3 2025 versus 18-31% on benchmarked legacy panels. The verification gap is what separates defensible data from contaminated data.

Process

How It Works

From research question to evidence-backed intelligence in four steps.

1
Day 1

Brief us

Tell us your study question and audience. Our research agent translates into a structured learning plan with objectives, key questions, and conversation flow. You review and edit before fielding starts.

2
Days 2-15

We recruit and moderate

Our AI moderator runs voice or video interviews with verified clinicians from our panel. License + NPI verification, behavioral fingerprinting, AI-on-AI fraud detection — all built in.

3
Days 16-18

We de-identify and deliver

Transcripts and recordings stripped of identifiers using HIPAA Safe Harbor methodology, then delivered to your team in standard formats your existing analysis stack already accepts.

4
Days 19-21

You analyze

Use whatever you already use — internal team, MarketSight, Forsta, Claude Enterprise, internal Snowflake. We feed the data your current vendors can't recruit for.

Use Cases

What Do Teams Use Carevoices For?

Buying-Process Studies

Understand physician decision drivers, switching behaviors, and competitive perceptions. The pharma-permitted version of patient journey research — buying-process studies run within the monthly subscription, fielding starts the same week the brief is locked.

Decision-driver maps, switching triggers, competitive moats

Message Validation & Stimuli Testing

Test concept boards, claim language, ad creative, and visual aids against your target HCP audience. Built-in stimuli approval workflow for FDA-relevant content. Multiple concept variants per study.

Resonance scores, optimization recommendations, FDA-compliant audit trail

Workforce + Patient Research

Hospital systems use Carevoices for retention drivers, EHR adoption, patient experience deep-dives. Pairs with existing Press Ganey or NRC quant for full picture.

Retention drivers, intervention priorities, leadership feedback

Quarterly Trackers

Brand performance tracking with HCPs across 4 waves per year. Recurring access through verified physician and nurse network — AI-native qualitative depth on top of quantitative scoring.

Quarterly brand-health, share-of-voice, longitudinal trend

Advisory Research (Asynchronous)

Async advisory-board-style research for medical affairs and KOL work. Voice and video interviews instead of scheduled meetings. Sunshine Act-compatible.

Strategic input from KOLs without travel coordination overhead

Clinical Trial Patient Experience

Patient experience research embedded in clinical trial operations. Recruitment, retention, dropout-driver, and satisfaction research for biotech sponsors and CROs.

Recruitment uplift, retention improvement, FDA-ready qualitative data

"We ran 1,203 patient interviews in 48 hours for one sponsor, with HIPAA-grade de-identified transcripts delivered straight into our analysis stack, and the AI moderator went deeper than our human moderators on the first round."

Stephane Nyombaire, CEO, Nivella Health

Methodology & Trust

Built for healthcare regulatory reality

Compliance is the wedge, not an afterthought. Every healthcare engagement covered under our BAA. Every transcript de-identified before delivery. Every byte stays in US regions.

Compliance Posture

  • BAA on every healthcare engagement
  • PHI-safe transcript pipeline (no training, no logging)
  • HIPAA Safe Harbor de-identification by default
  • US data residency — AWS and GCP US regions only
  • Sunshine Act / Open Payments-ready data handling

Panel Quality

  • License + NPI verified at intake
  • Specialty + practice setting profiled
  • Behavioral fingerprinting across interviews
  • AI-on-AI fraud detection built into moderator
  • Voice biometric continuity per interview

Delivery Discipline

  • Monthly subscription with 50 interviews included; always-on listening capability
  • Fielding starts the same week the brief is locked vs. 8-12 weeks per project for incumbents
  • Stimuli pre-approval workflow for FDA-relevant content
  • Audit trail per panelist per stimulus
  • Standard data formats — works with your existing analysis stack

In progress: SOC 2 Type II audit (in evidence-collection phase). Letter of audit attestation available on request to qualified prospects under NDA.

FAQs

Frequently Asked Questions

Yes. BAA is standard on every healthcare engagement, included in every contract. Custom terms accommodated when your legal team needs them. Template available on request before signature.
Default-blinded studies — your team never learns participant identity, so transfers of value typically don't trigger reporting. For unblinded engagements (advisory boards), we provide CMS-format export data for your sponsor's filing. Our panelist intake captures NPI, state license, specialty, and address — export-ready by design.
Typical 7-14 days for verified specialists in mainstream therapeutic areas like oncology, cardiology, and GI. Rare subspecialties run 14-28 days. We confirm panel feasibility upfront before fielding starts. Direct NPI outreach available for ultra-rare specialties not in our pre-recruited pool.
Every transcript we deliver has identifiers stripped using HIPAA Safe Harbor methodology. All 18 HIPAA identifiers automatically detected and redacted. Custom identifier rules per study. Re-identification key held by Carevoices under BAA, never shared. Expert determination de-identification available on request.
AI-native delivery, a monthly subscription with 50 interviews included replacing per-project RFP cycles, and compliance-as-architecture. Fielding starts the same week the brief is locked. AI moderation, BAA + HIPAA Safe Harbor + US data residency + AI-on-AI fraud detection, and de-identified delivery as an integrated stack. Engagement velocity, data integrity (0.4% verified leak rate), and procurement clearance (30-60 days).
We're in evidence-collection phase. Type I report expected within 90 days; Type II within 9-12 months. Letter of audit attestation available on request to qualified prospects under NDA. We do not claim certifications we don't yet hold.
Get Started

Get a demo

We'll show you a sample compliant deliverable from a recent study, walk through how the monthly subscription works, and answer your compliance team's questions on the call.

30-min with founder

Walkthrough of a sample compliant deliverable + how the monthly subscription fits your research backlog

For your legal team

BAA template, identifier stripping methodology, US data residency commitment